Morgan Stanley Maintains Overweight on UnitedHealth Group, Lowers Price Target to $610
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Overweight rating on UnitedHealth Group (NYSE:UNH) but lowers the price target from $615 to $610.

October 16, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley has maintained its Overweight rating on UnitedHealth Group but slightly reduced the price target from $615 to $610.
The Overweight rating suggests a positive outlook, but the slight reduction in the price target indicates a minor adjustment in expectations. This is likely to have a neutral short-term impact on the stock price as the overall sentiment remains positive.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100